Post by Baker McKenzie Wong & Leow

On 28 May 2026, Singapore’s Health Sciences Authority (HSA) published details of its recent webinar on regulatory updates for medical devices and in vitro diagnostics (IVDs), covering developments such as software medical device guidelines and the Artificial Intelligence in Healthcare Guidelines 2.0 (AIHGle 2.0). In this alert, our Healthcare & Life Sciences principals Andy Leck and Lim Ren Jun highlight the key regulatory developments and outline practical considerations for medical device companies navigating Singapore’s evolving framework. Read: https://lnkd.in/gt5aQG9g.